- 600 mg - Efavirenz;
- 200 mg - Emtricitabine;
- 300 mg - Tenofovir disoproxil fumarate;
- 245 mg - Tenofovir disoproxil;
Without a Prescription
Emtricitabine is prescribed for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment
of HIV-1 infection in adults.
Renal Impairment : Because Emtricitabine is a fixed-dose combination, it should not be prescribed for patients requiring dosage adjustment such as those with moderate or severe renal impairment (creatinine clearance <50 mL/min).
Adults : The dose of Emtricitabine is one tablet once daily taken on an empty stomach Dosing at bedtime may improve the tolerability of nervous system symptoms associated with efavirenz.
Pediatrics: Emtricitabine is not recommended for use in patients <18 years of age.
Emtricitabine is contraindicated in patients with previously demonstrated hypersensitivity to any of the components of the product
For some drugs, competition for CYP3A by efavirenz could result in inhibition of their metabolism and create the potential for
serious and/or life-threatening adverse reactions (eg cardiac arrhythmias, prolonged sedation, or respiratory depression).
Container of 30 tablets.